December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML
Feb 8, 2024, 05:16

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared on X:

Aza + ven + gilteritinib highly effective in newly diagnosed older FLT3-mutated AML: CR/CRi 96% and 18-month OS 72%. A new standard of care in this population.”

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Visit the article website.
Source: Hagop Kantarjian/X